//]]>

Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds (Record no. 18913)

000 -LEADER
fixed length control field 05471nam a22004815i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150254.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130228s2013 ne | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789400762145
978-94-007-6214-5
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC261-271
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 614.5999
Edition number 23
264 #1 -
-- Dordrecht :
-- Springer Netherlands :
-- Imprint: Springer,
-- 2013.
912 ## -
-- ZDB-2-SBL
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Fang, Evandro Fei.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds
Medium [electronic resource] /
Statement of responsibility, etc edited by Evandro Fei Fang, Tzi Bun Ng.
300 ## - PHYSICAL DESCRIPTION
Extent XIX, 423 p. 37 illus., 26 illus. in color.
Other physical details online resource.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PREFACE -- PART I. Lectins: From biological recognition molecules to variable medicinal applications -- Lectins: Personal Comments of Nathan Sharon Taken from His Memoirs (Translation from Hebrew) .-The History of Lectinology -- Animal and Human Lectins -- Lectins of Marine Origin and their Clinical Applications -- Medicinal applications of plant lectins -- PART II Structural and functional insights into medicinal ribonucleases -- Plant nucleases from nuclease I family: their properties and antitumor potential -- Bovine Seminal Ribonuclease and its special features: when two is better than one -- PART III The perspectives for ribosome inactivating proteins: unveiling the working mechanisms and potential medicinal benefits -- The Discovery of MAP30 and Elucidation of its Medicinal Activities -- Ribosome Inactivating Proteins from Plants: Biological Properties and their Use in Experimental Therapy -- Current status & Biomedical applications of Ribosome-inactivating proteins -- PART IV The research history of protease inhibitors and their health implications -- The Health Benefits of the Bowman-Birk Inhibitor -- Peptidic inhibitors of serine proteinases of plant origin -- Anti-tumor effect of synthetic serine protease inhibitor.-  A landscape of the health benefits of different natural protease inhibitors -- PART V Plethora of health benefits from small molecules: From bench-top to clinical settings -- Autophagy upregulation as a therapeutic strategy for neurodegenerative diseases -- Rapamycin – current and future uses -- Eating, drinking, smoking and cancer prevention: a focus on acetaldehyde -- The use of edible mushroom water soluble polysaccharides in the treatment and prevention of chronic diseases: a mechanistic approach -- Essential Oil Constituents: Biodiversity and their Applicability for Cancer Therapy -- PART VI Medicinal compounds from the garden: a bird’s eye view of one mushroom, one fruit, one insect, and others -- Recent research on pharmacological activities of the medicinal fungus Cordyceps sinensis -- The bitter fruit with sweet health benefits:A comprehensive synopsis of recent research progress on medicinal properties of Momordica charantia -- Bioactive constituents of the silk worm Bombyx mori -- Proteins with anticancer and antimicobial activities from mammals, submammalian vertebrates and invertebrates -- Defense proteins with antiproliferative and antimicrobial activities from fungi and bacteria -- PART VII  Modernizing investigations of traditional Chinese medicine at the molecular level -- The role of the GP-TCM Research Association to modernization and globalization of Traditional Chinese Medicine.-  High-throughput screening in traditional Chinese medicine-based drug discovery -- PART VIII Questions and future perspectives -- Achievements, questions arising and future outlook on the path to discover new medicinal compounds. Index.
520 ## - SUMMARY, ETC.
Summary, etc The modern unhealthy diet and lifestyle in conjunction with pathogens, environmental carcinogens and multiple other risk factors increase humans’ susceptibility to different diseases exemplified by elevated levels of cancers, cardiovascular and communicable diseases. Screening of potential drugs from medicinal plants and animals provides a promising strategy for the alleviation of the impact of these diseases. Components with potential medicinal applications include RIPs, RNases, lectins, protease inhibitors and numerous small compounds. These compounds have shown both preventive and therapeutic effects for humans. This book is a compilation of articles written by internationally renowned experts exploring the different uses of medicinal compounds in human therapeutics. Here we provide a comprehensive outlook on both qualitative and quantitative studies focusing on medicinal plants and animals, and establishing a link between laboratory research discovery and clinical applications.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Toxicology.
Topical term or geographic name as entry element Cytology.
Topical term or geographic name as entry element Biomedicine.
Topical term or geographic name as entry element Cancer Research.
Topical term or geographic name as entry element Apoptosis.
Topical term or geographic name as entry element Biomedicine general.
Topical term or geographic name as entry element Molecular Medicine.
Topical term or geographic name as entry element Pharmacology/Toxicology.
Topical term or geographic name as entry element Biomedicine general.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ng, Tzi Bun.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9789400762138
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-94-007-6214-5
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-08AUM Main Library2014-04-08 2014-04-08 E-Book   AUM Main Library614.5999
Languages: 
English |
العربية